Milestone Scientific (NYSE:MLSS) said today that its CompuFlo epidural computer-controlled anesthesia system won 510(k) clearance from the FDA. The Livingston, N.J.-based company’s CompuFlo Epidural instrument uses dynamic pressure sensing to help anesthesiologists correctly identify the epidural space and significantly reduce complications in real-time, according to Milestone. Get the full story at our sister site, Drug […]
milestonescientific
Milestone Scientific lands marketing clearance in Saudi Arabia, Australia
Milestone Scientific (NYSE:MLSS) shares rose today after the company said it won marketing clearance in Saudi Arabia, weeks after winning a regulatory nod in Australia for its epidural and intra-articular instruments. The company’s CompuFlo Epidural instrument uses dynamic pressure sensing to help anesthesiologists correctly identify the epidural space and significantly reduce complications, according to Milestone. The […]
Milestone Scientific closes $3m round
Milestone Scientific‘s (OTC:MLSS) said today it closed a $3 million round, selling approximately 2 million shares at $1.50 per share. Each share sold includes warrants for the purchase of an additional 0.75 common shares of stock, offering an additional total 1.5 million shares. Warrants offered in the round have a 3-year term and an exercise […]
Milestone Scientific prices $3m round
Milestone Scientific‘s (OTC:MLSS) today priced an upcoming offering, looking to raise approximately $3 million. The Livingston, N.J.-based company said it plans to offer 2 million shares of common stock at $1.50. Each share sold will include warrants for the purchase of an additional 0.75 common shares of stock, offering an additional total 1.5 million shares. […]
FDA denies Milestone Scientific’s Compu-Flo 510(k) application
Milestone Scientific‘s (OTC:MLSS) said today that the FDA denied the 510(k) application for its Compu-Flo intra-articular computer controlled injection system due to inadequate documentation showing that the device met required equivalency standards. The Livingston, N.J.-based company said that after meeting with the FDA’s Office of Device Evaluation, it plans to provide additional data, including a new […]
Milestone Scientific touts CompuFlo trial completion, plans FDA submission
Milestone Scientific‘s (OTC:MLSS) said today it completed the pivotal study of its CompuFlo epidural computer controlled system, investigating the safety and efficacy of the epidural space verification of the system. The 400-patient, multicenter pivotal Compass study looked to compare treatment with the CompuFlo device against the current standard of care for patients undergoing pain management and […]
Milestone Scientific looks to add $2m in follow-on round
Milestone Scientific (OTC:MLSS) said today it approved a follow-on round of financing, expecting to bring in between $1.7 and $2 million. Funds in the follow-on round will come from the private placement of unregistered common stock at $2 per share from investors who participated in the company’s 2014 financing round, the Livingston, N.J.-based company said. “We […]
Milestone Scientific claims CompuFlo meets interim goals in IDE trial
Milestone Scientific’s (OTC:MLSS) epidural & intra-articular subsidiary said today that the investigative device exemption trial of its CompuFlo epidural computer controlled system has returned successful interim results. The Compass trial is designed to asses the safety and effectiveness of the epidural space verification of CompuFlow, which identifies and confirms epidural space locations, Livingston, N.J.-based Milestone […]
Pulmonx taps ex-Asthmatx CEO French for the corner office | Personnel Moves
Pulmonx said yesterday that it named Glen French, the co-founder and CEO of Asthmatx who led it to an acquisition by BSX, to be its new president and chief executive.
Milestone Scientific drops on dermatology joint venture plan
Milestone Scientific raises another $1.5M, releases Q3 earnings
Milestone Scientific (OTC:MLSS) said its subsidiary, Milestone Medical, sold $1.5 million of stock to European investors, bringing its total European fundraising efforts to $3 million.